Sonoma Pharmaceuticals, Inc. (SNOA)
USD 2.53
(-2.32%)
USD 2.53
(-2.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 12.73 Million | 13.27 Million | 12.62 Million | 18.62 Million | 18.93 Million | 18.97 Million |
| Cost of Revenue | 7.99 Million | 8.79 Million | 8.63 Million | 12.07 Million | 10.6 Million | 10.09 Million |
| Gross Profit | 4.74 Million | 4.47 Million | 3.99 Million | 6.55 Million | 8.33 Million | 8.88 Million |
| Operating Expenses | 9.44 Million | 9.04 Million | 9.88 Million | 10 Million | 15 Million | 20.13 Million |
| Selling, General and Administrative Expenses | 7.57 Million | 8.84 Million | 9.75 Million | 9.45 Million | 13.66 Million | 18.62 Million |
| Research and Development Expenses | 1.87 Million | 207 Thousand | 125 Thousand | 555 Thousand | 1.33 Million | 1.51 Million |
| Other Expenses | - | -631 Thousand | -394 Thousand | -594 Thousand | 240 Thousand | -239 Thousand |
| Cost and Expenses | 17.43 Million | 17.84 Million | 18.51 Million | 22.07 Million | 25.6 Million | 30.22 Million |
| Operating Income | -4.7 Million | -4.57 Million | -5.88 Million | -3.44 Million | -6.67 Million | -11.25 Million |
| Interest Expense | - | 16 Thousand | 10 Thousand | 12 Thousand | 16 Thousand | 33 Thousand |
| Income Tax Expense | -196 Thousand | -33 Thousand | -332 Thousand | 713 Thousand | 121 Thousand | 458 Thousand |
| Earnings before Tax | -5.03 Million | -5.18 Million | -5.41 Million | -3.9 Million | -2.82 Million | -11.34 Million |
| Net Income | -4.83 Million | -5.15 Million | -5.08 Million | -4.61 Million | -2.94 Million | -11.79 Million |
| Earnings Per Share Basic | -10.64 | -30.40 | -38.40 | -46.20 | -39.80 | -255.40 |
| Earnings Per Share Diluted | -10.64 | -30.40 | -38.40 | -46.20 | -39.80 | -255.40 |
| Weighted Average Shares Outstanding | 454.5 Thousand | 169.7 Thousand | 132.65 Thousand | 99.8 Thousand | 73.85 Thousand | 46.19 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 454.5 Thousand | 169.7 Thousand | 132.65 Thousand | 99.8 Thousand | 73.85 Thousand | 46.2 Thousand |
| Gross Margin | 0.37 | 0.34 | 0.32 | 0.35 | 0.44 | 0.47 |
| EBIT Margin | -0.36 | -0.33 | -0.52 | -0.20 | -0.32 | -0.57 |
| Profit Margin | -0.38 | -0.39 | -0.40 | -0.25 | -0.16 | -0.62 |
| EBITDA | -4.52 Million | -4.44 Million | -5.7 Million | -3.22 Million | -3.21 Million | -10.85 Million |
| Earnings Before Tax Margin | -0.37 | -0.34 | -0.47 | -0.19 | -0.35 | -0.59 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 3.43 Million | 12.73 Million | 3.13 Million | 2.73 Million | 3.42 Million | 13.27 Million |
| Cost of Revenue | 2.34 Million | 7.99 Million | 1.67 Million | 1.74 Million | 2.22 Million | 8.79 Million |
| Gross Profit | 1.09 Million | 4.74 Million | 1.46 Million | 990 Thousand | 1.2 Million | 4.47 Million |
| Operating Expenses | 2.5 Million | 9.44 Million | 2.3 Million | 2.19 Million | 2.44 Million | 9.04 Million |
| Selling, General and Administrative Expenses | 2.09 Million | - | 1.7 Million | 1.66 Million | 2.11 Million | - |
| Research and Development Expenses | 409 Thousand | - | 601 Thousand | 536 Thousand | 325 Thousand | - |
| Other Expenses | 50 Thousand | -330 Thousand | -79 Thousand | -90 Thousand | -211 Thousand | -631 Thousand |
| Cost and Expenses | 4.84 Million | 17.43 Million | 3.98 Million | 3.93 Million | 4.66 Million | 17.84 Million |
| Operating Income | -1.4 Million | -4.7 Million | -844 Thousand | -1.2 Million | -1.24 Million | -4.57 Million |
| Interest Expense | - | - | - | - | - | 16 Thousand |
| Income Tax Expense | -292 Thousand | -196 Thousand | -57 Thousand | 186 Thousand | -33 Thousand | -33 Thousand |
| Earnings before Tax | -1.35 Million | -5.03 Million | -923 Thousand | -1.29 Million | -1.45 Million | -5.18 Million |
| Net Income | -1.06 Million | -4.83 Million | -866 Thousand | -1.48 Million | -1.41 Million | -5.15 Million |
| Earnings Per Share Basic | -0.07 | - | -0.08 | -0.29 | -0.29 | - |
| Earnings Per Share Diluted | -0.07 | - | -0.08 | -0.29 | -0.29 | - |
| Weighted Average Shares Outstanding | 15.6 Million | 9.09 Million | 10.9 Million | 5.16 Million | 4.93 Million | 3.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.6 Million | 9.09 Million | 10.9 Million | 5.16 Million | 4.93 Million | 3.39 Million |
| Gross Margin | 0.32 | 0.37 | 0.47 | 0.36 | 0.35 | 0.34 |
| EBIT Margin | -0.40 | - | -0.25 | -0.43 | -0.35 | - |
| Profit Margin | -0.31 | -0.38 | -0.28 | -0.54 | -0.41 | -0.39 |
| EBITDA | -1.36 Million | - | -799 Thousand | -1.16 Million | -1.19 Million | - |
| Earnings Before Tax Margin | -0.41 | -0.37 | -0.27 | -0.44 | -0.36 | -0.34 |
5206
MFC-PC
GSPL
RLLVF
LSRG
300573